An orthogonal approach to lipid nanoparticle analysis is recommended to optimize drug development success.
Hanna Jankevics Jones
Advertisement
Hanna Jankevics Jones, PhD, is a pharmaceutical segment marketing manager at Malvern Panalytical.
Articles by Hanna Jankevics Jones
Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.
Advertisement
Latest Updated Articles
Shining a Light on Lipid Nanoparticle CharacterizationPublished: September 15th 2022 | Updated:
- Taking a Closer Look at Lipid Nanoparticle Characterization
Published: November 8th 2022 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Ask the Expert: Commenting on Draft Regulations
2
SK pharmteco Invests in California Site to Overcome Peptide Purification Bottlenecks
3
Global Study Confirms Survival Advantage of Mogamulizumab in Advanced Mycosis Fungoides and Sézary Syndrome
4
Behind the Headlines Episode 27: Unpacking Mega Deals and R&D Directions
5
